Prime Medicine, Inc. (PRME)
(Delayed Data from NSDQ)
$4.67 USD
+0.66 (16.46%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $4.99 +0.32 (6.85%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Prime Medicine, Inc. has a market cap of $539.64M, which represents its share price of $4.01 multiplied by its outstanding shares number of 134.57M. As a small-cap company, PRME's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
PRME 4.67 +0.66(16.46%)
Will PRME be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PRME based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PRME
Prime Medicine, Inc. (PRME) Reports Q2 Loss, Lags Revenue Estimates
Prime Medicine, Inc. (PRME) Now Trades Above Golden Cross: Time to Buy?
PRME: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Genomics Stocks Worth Adding to Your Portfolio in 2025
Biotech Stock Roundup: BMRN to Acquire INZY, NVAX Gains on Vaccine Approval & More
Prime Medicine, Inc. (PRME) Reports Q1 Loss, Misses Revenue Estimates
Other News for PRME
Upper Bollinger Band Walk appears for PRME after 1.47% move
NR7 appears for PRME after 0.25% move
Prime Drink Group Granted Extension for Financial Filings
Stochastic Sell Signal appears for PRME after 4.88% move
PRME forms Bearish Engulfing on September 10